Novel system for organ preservation in liver transplantation: Feed macrophages with ceria nanoparticles [0.03%]
肝脏移植中器官保存的新系统：用二氧化铈纳米颗粒喂养巨噬细胞
Yongquan Chi,Jinhua Song,Junda Li et al.
Yongquan Chi et al.
Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China: a systematic literature review and meta-analysis [0.03%]
中国慢性血栓栓塞性肺动脉高压的流行病学及管理方案：系统文献回顾和荟萃分析
Wanmu Xie,Yongpei Yu,Qiang Huang et al.
Wanmu Xie et al.
Practice guidelines for diagnosis, treatment, and prevention of tuberculosis in patients with rheumatic disease [0.03%]
风湿病患者结核病的诊断、治疗和预防实践指南
Collaborative Group for Tuberculosis Prevention and Control in Patients with Rheumatic disease in China;;Chinese Society of Clinical Epidemiology and Evidence-Based Medicine, Chinese Medical Association;;Chi
Collaborative Group for Tuberculosis Prevention and Control in Patients with Rheumatic disease in China;;Chinese Society of Clinical Epidemiology and Evidence-Based Medicine
Real-world long-term outcomes of non-small cell lung cancer patients undergoing neoadjuvant treatment with or without immune checkpoint inhibitors [0.03%]
接受免疫检查点抑制剂新辅助治疗的非小细胞肺癌患者的现实世界长期预后研究
Bolun Zhou,Lin Li,Fan Zhang et al.
Bolun Zhou et al.
Background: Immune checkpoint inhibitors (ICIs) have been included in various neoadjuvant therapy (NAT) regimens for non-small cell lung cancer (NSCLC). However, due to the relatively short period for the use of ICIs in N...
Characteristics of untargeted metabolomics of common bacterial pathogens in respiratory diseases [0.03%]
呼吸疾病常见细菌病原体的非靶向代谢组学特征
Yue Hu,Qin Li,Wenjing Wang et al.
Yue Hu et al.
Ting Li,Wenting Yu,Wenyang Lei et al.
Ting Li et al.
Xinyi Wang,Youlin Long,Tengyue Hu et al.
Xinyi Wang et al.
Xinyu Zhang,Jiangshan He,Yiming Shao
Xinyu Zhang
Oncolytic virotherapy is a promising therapeutic approach treating tumors, where oncolytic viruses (OVs) can selectively infect and lyse tumor cells through replication, while also triggering long-lasting anti-tumor immune responses. Vaccin...
Adiposity, circulating metabolic markers, and risk of cardiometabolic multimorbidity [0.03%]
adiposity, 循环代谢标志物和心血管代谢多重病症的风险
译为：
肥胖程度，循环代谢标志物和心血管代谢多重疾病的风险
Si Cheng,Zhiqing Zeng,Jun Lv et al.
Si Cheng et al.
Primary regional disparities in clinical characteristics, treatments, and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China: Insights from the China-VHD Study [0.03%]
中国46家三级医院心瓣膜病临床特征、治疗和预后的主要区域差异：中国VHD研究的启示
Xiangming Hu,Yunqing Ye,Zhe Li et al.
Xiangming Hu et al.
Background: Valvular heart disease (VHD) has become increasingly common with the aging in China. This study aimed to evaluate regional differences in the clinical features, management strategies, and outcomes of patients ...